![]() |
|
|
Most-read rankings are recalculated at the beginning of the month and are based on full-text and pdf views.
| 21. | Rengasamy RM Maran, Ann Thomas, Magen Roth, Zhonghua Shen, Noriko Esterly, David Pinson, Xin Gao, Yawei Zhang, Vadivel Ganapathy, Frank Gonzalez, Grace L Guo | ||
| FXR Deficiency in Mice Leads to Increased Intestinal Epithelial Cell Proliferation and Tumor Development | |||
|---|---|---|---|
|
J. Pharmacol. Exp. Ther. Nov 03, 2008; doi: 10.1124/jpet.108.145409.
(In "GASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL") |
|||
| 22. | Soyong Jang, Jae-Chul Jung, Dong Hyun Kim, Jong Hoon Ryu, Yongnam Lee, Mankil Jung, Seikwan Oh | ||
| The neuroprotective effects of benzylideneacetophenone derivatives on excitotoxicity and inflammation via pJAK2/pSTAT3 and MAPK pathways | |||
|
J. Pharmacol. Exp. Ther. Nov 04, 2008; doi: 10.1124/jpet.108.144014.
(In "NEUROPHARMACOLOGY") |
|||
| 23. | Howard L. Kaplan, Usoa E. Busto, Godofredo J. Baylon, Siu W. Cheung, S. Victoria Otton, Gail Somer, Edward M. Sellers | ||
| Inhibition of Cytochrome P450 2D6 Metabolism of Hydrocodone to Hydromorphone Does Not Importantly Affect Abuse Liability | |||
|
J. Pharmacol. Exp. Ther. Apr 01, 1997; 281: 103-108.
(In "DRUG METABOLISM AND DISPOSITION") |
|||
| 24. | Charles F. Minto, Christopher Howe, Susan Wishart, Ann J. Conway, David J. Handelsman | ||
| Pharmacokinetics and Pharmacodynamics of Nandrolone Esters in Oil Vehicle: Effects of Ester, Injection Site and Injection Volume | |||
|
J. Pharmacol. Exp. Ther. Apr 01, 1997; 281: 93-102.
(In "DRUG METABOLISM AND DISPOSITION") |
|||
| 25. | Edward Perez-Reyes, Amy L. Van Deusen, Iuliia Vitko | ||
| Molecular pharmacology of human Cav3.2 T-type Ca2+ channels: Block by antihypertensives, antiarrhythmics, and their analogs | |||
|
J. Pharmacol. Exp. Ther. Oct 30, 2008; doi: 10.1124/jpet.108.145672.
(In "CARDIOVASCULAR PHARMACOLOGY") |
|||
| 26. | Hyoung-gon Lee, Xiongwei Zhu, Rudy J. Castellani, Akihiko Nunomura, George Perry, Mark A. Smith | ||
Amyloid- in Alzheimer Disease: The Null versus the Alternate Hypotheses |
|||
|
J. Pharmacol. Exp. Ther. Jun 01, 2007; 321: 823-829.
(In "PERSPECTIVES IN PHARMACOLOGY") |
|||
| 27. | Sharanya Vemula, Karen Roder, Tianzhi Yang, G. Jayarama Bhat, Thomas J. Thekkumkara, Thomas J. Abbruscato | ||
| A functional role for sodium dependent glucose transport across the blood-brain barrier during oxygen glucose deprivation | |||
|
J. Pharmacol. Exp. Ther. Nov 03, 2008; doi: 10.1124/jpet.108.146589.
(In "NEUROPHARMACOLOGY") |
|||
| 28. | David Fulton, Jean-Philippe Gratton, William C. Sessa | ||
| Post-Translational Control of Endothelial Nitric Oxide Synthase: Why Isn't Calcium/Calmodulin Enough? | |||
|
J. Pharmacol. Exp. Ther. Dec 01, 2001; 299: 818-824.
(In "PERSPECTIVES IN PHARMACOLOGY") |
|||
| 29. | Iris Hecht, Rong Jiang, Andre LF Sampaio, Chen Hermesh, Caleb Rutledge, Ronen Shemesh, Amir Toporik, Merav Beiman, Liat Dassa, Hagit Niv, Gady Cojocaru, Arie Zauberman, Galit Rotman, Mauro Perretti, Jakob Vinten-Johansen, Yossi Cohen | ||
| A novel peptide agonist of FPRL1 (ALX) displays anti-inflammatory and cardioprotective effects | |||
|
J. Pharmacol. Exp. Ther. Nov 20, 2008; doi: 10.1124/jpet.108.145821.
(In "CARDIOVASCULAR PHARMACOLOGY") |
|||
| 30. | Kazuhiro Ito, Gaetano Caramori, Ian M. Adcock | ||
| Therapeutic Potential of Phosphatidylinositol 3-Kinase Inhibitors in Inflammatory Respiratory Disease | |||
|
J. Pharmacol. Exp. Ther. Apr 01, 2007; 321: 1-8.
(In "PERSPECTIVES IN PHARMACOLOGY") |
|||
| [Previous 10 Articles] [Next 10 Articles] | |||
= from the current issue
Last Updated: 12/09/2008 15:09:47